Key points from article :
A recent study led by Professor Ioakim Spyridopoulos from Newcastle University highlights the potential of TA-65®, a dietary supplement, in improving recovery outcomes for heart attack patients. Conducted in collaboration with The James Cook University Hospital, the research focuses on TA-65®'s ability to counteract immunosenescence (the ageing of the immune system) and reduce inflammation, a major contributor to post-heart attack complications.
Published in GeroScience, the findings are striking: TA-65® was shown to decrease inflammation by up to 62% while simultaneously boosting immune cell production. Unlike traditional anti-inflammatory drugs that suppress immunity, TA-65® offers a dual benefit by reducing inflammation without compromising the immune system, making it a unique therapeutic option.
The supplement also appears to promote mitochondrial health, enhancing overall vitality and resilience. Healthy mitochondria are essential for cellular energy and recovery, particularly after a myocardial infarction (heart attack). With its proven safety and accessibility, TA-65® offers a novel approach to managing immune and inflammatory challenges in heart attack recovery.
TA-65® is widely available through T.A. Sciences® and healthcare providers, representing a safe and effective way to support immunity and cellular health during recovery.
